
Number of publications published per year by Matsuura, Kentaro. (Source : PubMed)

Distribution of publications types for Matsuura, Kentaro. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Evaluation of efficacy and safety of generic levofolinate in patients who received colorectal cancer chemotherapy.
Med. Oncol.
2010
MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta.
Cancer Res.
2010;70;6
Molecular and genetic studies suggest that thyroid hormone receptor is both necessary and sufficient to mediate the developmental effects of thyroid hormone.
Gen. Comp. Endocrinol.
2010
Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer.
Int. J. Cancer
2010
Genomic profiling of gastric carcinoma in situ and adenomas by array-based comparative genomic hybridization.
J. Pathol.
2010
Fabricating small-scale, curved, polymeric structures with convex and concave menisci through interfacial free energy equilibrium.
Lab Chip
2009;9;22
FOXP3 expression of micrometastasis-positive sentinel nodes in breast cancer patients.
Oncol. Rep.
2009;22;5
Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.
Nat. Genet.
2009;41;10
Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy.
Clin Ther
2009;31;10

Results of a preliminary study using hypofractionated involved-field radiation therapy and concurrent carboplatin/paclitaxel in the treatment of locally advanced non-small-cell lung cancer.
Int. J. Clin. Oncol.
2009;14;5
[ See timeline ] [ See all publications ]
means that Matsuura, Kentaro has 15 papers cited a least 15 times - methodology
Department of Pharmacy, Gifu University Hospital, Gifu, Japan.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.